Cite
HARVARD Citation
Hsu, J. et al. (n.d.). XL092, a multi-targeted inhibitor of MET, VEGFR2, AXL and MER with an optimized pharmacokinetic profile. European journal of cancer. pp. S16-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hsu, J. et al. (n.d.). XL092, a multi-targeted inhibitor of MET, VEGFR2, AXL and MER with an optimized pharmacokinetic profile. European journal of cancer. pp. S16-. [Online].